{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:50:24Z","timestamp":1791586224865,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,9]],"date-time":"2027-10-09T00:00:00Z","timestamp":1823040000000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging Clinics of North America"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.mric.2026.06.007","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:19:47Z","timestamp":1784546387000},"page":"649-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["MR Imaging of Anal Cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Peter M.","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Golia Pernicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy D.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaiane M.","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.mric.2026.06.007_bib2","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199711063371904","article-title":"Sexually transmitted infection as a cause of anal cancer","volume":"337","author":"Frisch","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mric.2026.06.007_bib3","article-title":"High grade anal dysplasia in people living with HIV: a review of the anal Cancer\/HSIL outcomes research (ANCHOR) trial. Implications for screening and treatment strategies to minimize anal cancer in a very high-risk population","volume":"3","author":"Aboulafia","year":"2023","journal-title":"Int J Cancer Care Deliv"},{"issue":"2","key":"10.1016\/j.mric.2026.06.007_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis","volume":"18","author":"Lin","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.mric.2026.06.007_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00795-011-0541-8","article-title":"Morphology of the epithelium of the lower rectum and the anal canal in the adult human","volume":"45","author":"Tanaka","year":"2012","journal-title":"Med Mol Morphol"},{"issue":"3","key":"10.1016\/j.mric.2026.06.007_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2559.1991.tb00831.x","article-title":"Melanocytes in the anal canal epithelium","volume":"18","author":"Clemmensen","year":"1991","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.mric.2026.06.007_bib7","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/tomography9050135","article-title":"An updated review on imaging and staging of anal Cancer\u2014not just rectal cancer","volume":"9","author":"Congedo","year":"2023","journal-title":"Tomography"},{"issue":"12","key":"10.1016\/j.mric.2026.06.007_bib8","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1158\/1078-0432.CCR-24-2575","article-title":"Time dependency for human papillomavirus circulating tumor dna detection after chemoradiation as a prognostic biomarker for localized anal cancer","volume":"31","author":"Morris","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mric.2026.06.007_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2340\/1651-226X.2025.41288","article-title":"The clinical utility of circulating human papillomavirus across squamous cell carcinomas","volume":"64","author":"Spindler","year":"2025","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.mric.2026.06.007_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.6004\/jnccn.2023.0030","article-title":"Anal carcinoma, version 2.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Benson","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"issue":"4","key":"10.1016\/j.mric.2026.06.007_bib11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00330-010-1980-7","article-title":"Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up","volume":"21","author":"Parikh","year":"2011","journal-title":"Eur Radiol"},{"issue":"1080","key":"10.1016\/j.mric.2026.06.007_bib12","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170370","article-title":"PET imaging in anal canal cancer: a systematic review and meta-analysis","volume":"90","author":"Mahmud","year":"2017","journal-title":"Br J Radiol"},{"issue":"9","key":"10.1016\/j.mric.2026.06.007_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","article-title":"Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Rao","year":"2021","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.mric.2026.06.007_bib14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/DCR.0000000000001114","article-title":"ASCS (the American Society of Colon and Rectal Surgeons) clinical practice guidelines for anal squamous cell cancers (revised 2018)","volume":"61","author":"Stewart","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.mric.2026.06.007_bib15","doi-asserted-by":"crossref","first-page":"S396","DOI":"10.1016\/j.jacr.2025.02.018","article-title":"ACR appropriateness criteria\u00ae staging and Follow-up of anal cancer","volume":"22","author":"Horvat","year":"2025","journal-title":"J Am Coll Radiol"},{"issue":"11","key":"10.1016\/j.mric.2026.06.007_bib16","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1007\/s00330-023-09942-0","article-title":"Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma","volume":"33","author":"Prezzi","year":"2023","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.mric.2026.06.007_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1148\/rg.321115040","article-title":"MR imaging evaluation of perianal fistulas: spectrum of imaging features","volume":"32","author":"De Miguel Criado","year":"2012","journal-title":"Radiographics"},{"issue":"11","key":"10.1016\/j.mric.2026.06.007_bib19","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1007\/s00261-019-02020-4","article-title":"MR staging of anal cancer: what the radiologist needs to know","volume":"44","author":"Golia Pernicka","year":"2019","journal-title":"Abdom Radiol"},{"issue":"14","key":"10.1016\/j.mric.2026.06.007_bib20","doi-asserted-by":"crossref","first-page":"22980","DOI":"10.18632\/oncotarget.14946","article-title":"Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer","volume":"8","author":"Reginelli","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.mric.2026.06.007_bib21","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s11605-009-0870-2","article-title":"Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging","volume":"13","author":"Otto","year":"2009","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.mric.2026.06.007_bib22","doi-asserted-by":"crossref","first-page":"W335","DOI":"10.2214\/AJR.11.8027","article-title":"Imaging of anal carcinoma","volume":"199","author":"Kochhar","year":"2012","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.mric.2026.06.007_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mric.2019.09.005","article-title":"Staging of anal cancer","volume":"28","author":"Maas","year":"2020","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"01","key":"10.1016\/j.mric.2026.06.007_bib24","doi-asserted-by":"crossref","first-page":"041","DOI":"10.1055\/s-0043-1762928","article-title":"Cancer in anal fistulas","volume":"37","author":"Perez","year":"2024","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.mric.2026.06.007_bib25","unstructured":"Goodman KA, Gollub M, Brierley J, et al. AJCC Cancer Staging System: Anus: Version 9 of the AJCC Cancer Staging System. 9th ed. (Washington MK, ed.). 2023."},{"issue":"4","key":"10.1016\/j.mric.2026.06.007_bib26","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s00261-023-04182-8","article-title":"MRI morphological characteristics of lymph nodes in anal squamous cell carcinoma","volume":"49","author":"Gulevski","year":"2024","journal-title":"Abdom Radiol"},{"issue":"1","key":"10.1016\/j.mric.2026.06.007_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00259-023-06393-z","article-title":"[18F]-FDG PET in anal canal cancer: a systematic review and meta-analysis","volume":"51","author":"Mirshahvalad","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"3","key":"10.1016\/j.mric.2026.06.007_bib28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2008.04.003","article-title":"Assessing the impact of FDG-PET in the management of anal cancer","volume":"87","author":"Nguyen","year":"2008","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.mric.2026.06.007_bib29","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1245\/s10434-015-4391-9","article-title":"The role of FDG-PET in the initial staging and response assessment of anal cancer: a systematic review and meta-analysis","volume":"22","author":"Jones","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.mric.2026.06.007_bib30","unstructured":"WHO Classification of Tumours Editorial Board (World Health Organization). Digestive System Tumours. 5th ed. International Agency for Research on Cancer; 2019."},{"issue":"3","key":"10.1016\/j.mric.2026.06.007_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ssu.2980100312","article-title":"Anal adenocarcinoma: a comprehensive review","volume":"10","author":"Tarazi","year":"1994","journal-title":"Semin Surg Oncol"},{"issue":"8","key":"10.1016\/j.mric.2026.06.007_bib32","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1002\/cam4.2076","article-title":"Anal adenocarcinoma: treatment outcomes and trends in a rare disease entity","volume":"8","author":"Wegner","year":"2019","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.mric.2026.06.007_bib33","doi-asserted-by":"crossref","first-page":"078","DOI":"10.1055\/s-2006-942348","article-title":"Anal melanoma","volume":"19","author":"Singer","year":"2006","journal-title":"Clin Colon Rectal Surg"},{"issue":"02","key":"10.1016\/j.mric.2026.06.007_bib34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-0029-1223844","article-title":"Anorectal melanoma","volume":"22","author":"Row","year":"2009","journal-title":"Clin Colon Rectal Surg"},{"issue":"2","key":"10.1016\/j.mric.2026.06.007_bib35","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.2214\/AJR.17.18807","article-title":"Journal CLUB: primary anorectal melanoma: MRI findings and clinicopathologic correlations","volume":"211","author":"Park","year":"2018","journal-title":"Am J Roentgenol"},{"issue":"8","key":"10.1016\/j.mric.2026.06.007_bib36","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.mric.2026.06.007_bib37","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/BF02238576","article-title":"Changing epidemiology of anorectal melanoma","volume":"42","author":"Cagir","year":"1999","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.mric.2026.06.007_bib38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3748\/wjg.v17.i6.697","article-title":"Primary gastrointestinal lymphoma","volume":"17","author":"Ghimire","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"03","key":"10.1016\/j.mric.2026.06.007_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0031-1285997","article-title":"Colorectal lymphoma","volume":"24","author":"Times","year":"2011","journal-title":"Clin Colon Rectal Surg"},{"issue":"1","key":"10.1016\/j.mric.2026.06.007_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4251\/wjgo.v3.i1.14","article-title":"Primary colorectal lymphoma: an overview","volume":"3","author":"Stanojevic","year":"2011","journal-title":"World J Gastrointest Oncol"},{"issue":"5","key":"10.1016\/j.mric.2026.06.007_bib41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000478-198307000-00009","article-title":"Aggressive angiomyxoma of the female pelvis and perineum: report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm","volume":"7","author":"Steeper","year":"1983","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.mric.2026.06.007_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1097-0142(19960701)78:1<79::AID-CNCR13>3.0.CO;2-4","article-title":"Aggressive angiomyxoma: a clinicopathologic study of 29 female patients","volume":"78","author":"Fetsch","year":"1996","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.mric.2026.06.007_bib43","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2214\/AJR.13.11668","article-title":"Aggressive angiomyxomas: a comprehensive imaging review with clinical and histopathologic correlation","volume":"202","author":"Surabhi","year":"2014","journal-title":"Am J Roentgenol"},{"issue":"5350","key":"10.1016\/j.mric.2026.06.007_bib44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-Function mutations of c- kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mric.2026.06.007_bib45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2005.40709.x","article-title":"The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000","volume":"100","author":"Tran","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.mric.2026.06.007_bib46","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00330-005-2647-7","article-title":"Gastrointestinal stromal tumors: CT and MRI findings","volume":"15","author":"Sandrasegaran","year":"2005","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.mric.2026.06.007_bib47","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: a preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.mric.2026.06.007_bib48","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2009.09.029","article-title":"Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning","volume":"78","author":"Wright","year":"2010","journal-title":"Int J Radiat Oncol"},{"issue":"35","key":"10.1016\/j.mric.2026.06.007_bib49","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.mric.2026.06.007_bib50","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d72 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.mric.2026.06.007_bib51","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/cancers17091511","article-title":"Management of squamous cell carcinomas of the anal canal and anal margin after failure of chemoradiotherapy treatment: a narrative review","volume":"17","author":"Racine","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.mric.2026.06.007_bib52","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijrobp.2021.08.008","article-title":"Long-term outcomes of NRG Oncology\/RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-Fluorouracil and Mitomycin-C for the reduction of acute morbidity in anal canal cancer","volume":"112","author":"Kachnic","year":"2022","journal-title":"Int J Radiat Oncol"},{"issue":"6","key":"10.1016\/j.mric.2026.06.007_bib53","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/codi.14569","article-title":"A systematic review of outcomes after salvage abdominoperineal resection for persistent or recurrent anal squamous cell cancer","volume":"21","author":"Ko","year":"2019","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.mric.2026.06.007_bib54","article-title":"Advances in anal cancer treatment: current standards, the role of immunotherapy and emerging strategies","author":"Ntellas","year":"2025","journal-title":"ESMO Gastrointest Oncol"},{"key":"10.1016\/j.mric.2026.06.007_bib55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amsu.2020.04.016","article-title":"Squamous cell anal cancer: management and therapeutic options","volume":"55","author":"Pessia","year":"2020","journal-title":"Ann Med Surg"},{"issue":"9","key":"10.1016\/j.mric.2026.06.007_bib56","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/bjc.2014.467","article-title":"Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option","volume":"111","author":"Meulendijks","year":"2014","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.mric.2026.06.007_bib57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijrobp.2007.12.012","article-title":"EXTRA\u2014A multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer","volume":"72","author":"Glynne-Jones","year":"2008","journal-title":"Int J Radiat Oncol"},{"issue":"22","key":"10.1016\/j.mric.2026.06.007_bib58","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1200\/JCO.19.03266","article-title":"International rare cancers initiative multicenter randomized phase ii trial of cisplatin and fluorouracil versus carboplatin and paclitaxel in advanced anal cancer: interaact","volume":"38","author":"Rao","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.mric.2026.06.007_bib59","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1470-2045(17)30104-3","article-title":"Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study","volume":"18","author":"Morris","year":"2017","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.mric.2026.06.007_bib60","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S2468-1253(21)00382-4","article-title":"Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study","volume":"7","author":"Marabelle","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10495","key":"10.1016\/j.mric.2026.06.007_bib61","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(25)00631-2","article-title":"Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303\/InterAACT-2): a global, phase 3 randomised controlled trial","volume":"405","author":"Rao","year":"2025","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.mric.2026.06.007_bib62","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.3390\/healthcare11233010","article-title":"Recent advances in the management of anal cancer","volume":"11","author":"Upadhyay","year":"2023","journal-title":"Healthcare"},{"issue":"1","key":"10.1016\/j.mric.2026.06.007_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.soc.2016.07.002","article-title":"Diagnosis and diagnostic imaging of anal canal cancer","volume":"26","author":"Ciombor","year":"2017","journal-title":"Surg Oncol Clin N Am"},{"issue":"2","key":"10.1016\/j.mric.2026.06.007_bib64","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00330-016-4337-z","article-title":"The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer","volume":"27","author":"Kochhar","year":"2017","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1016\/j.mric.2026.06.007_bib65","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1007\/s00261-023-03895-0","article-title":"Follow-up imaging of anal cancer after treatment","volume":"48","author":"El","year":"2023","journal-title":"Abdom Radiol NY"},{"issue":"1","key":"10.1016\/j.mric.2026.06.007_bib66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2009.04.020","article-title":"Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer","volume":"77","author":"Mistrangelo","year":"2010","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.mric.2026.06.007_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71577-8","article-title":"Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients","volume":"10","author":"Slim","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.mric.2026.06.007_bib68","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/codi.14691","article-title":"Prognostic value of fluorodeoxyglucose positron emission tomography\/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer","volume":"21","author":"De Nardi","year":"2019","journal-title":"Colorectal Dis"},{"issue":"8","key":"10.1016\/j.mric.2026.06.007_bib69","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1007\/s00330-022-08648-z","article-title":"Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy","volume":"32","author":"Adusumilli","year":"2022","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.mric.2026.06.007_bib70","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.adro.2017.04.007","article-title":"Quantitative FDG-PET\/CT predicts local recurrence and survival for squamous cell carcinoma of the anus","volume":"2","author":"Cardenas","year":"2017","journal-title":"Adv Radiat Oncol"},{"issue":"6","key":"10.1016\/j.mric.2026.06.007_bib71","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/1754-9485.13566","article-title":"Pre- and post-treatment FDG PET-CT as a predictor of patient outcomes in anal squamous cell carcinoma: a systematic review and meta-analysis","volume":"67","author":"Mac Curtain","year":"2023","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"6","key":"10.1016\/j.mric.2026.06.007_bib72","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3393\/ac.2020.12.29","article-title":"Survival and operative outcomes after salvage surgery for recurrent or persistent anal cancer","volume":"36","author":"Park","year":"2020","journal-title":"Ann Coloproctology"},{"issue":"3","key":"10.1016\/j.mric.2026.06.007_bib73","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3390\/curroncol30030246","article-title":"Anal cancer: the past, present and future","volume":"30","author":"Gondal","year":"2023","journal-title":"Curr Oncol"},{"issue":"3","key":"10.1016\/j.mric.2026.06.007_bib74","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.rcl.2024.11.002","article-title":"MR imaging of anal","volume":"63","author":"Nincevic","year":"2025","journal-title":"Cancer. Radiol Clin North Am"},{"issue":"22","key":"10.1016\/j.mric.2026.06.007_bib75","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1158\/1078-0432.CCR-18-0922","article-title":"Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal squamous cell carcinoma","volume":"24","author":"Cabel","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.mric.2026.06.007_bib76","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1158\/1078-0432.CCR-18-2984","article-title":"Clinical validity of HPV circulating tumor DNA in advanced anal carcinoma: an ancillary study to the Epitopes-HPV02 trial","volume":"25","author":"Bernard-Tessier","year":"2019","journal-title":"Clin Cancer Res"}],"container-title":["Magnetic Resonance Imaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968926000619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968926000619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:15:05Z","timestamp":1791584105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064968926000619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1064968926000619"],"URL":"https:\/\/doi.org\/10.1016\/j.mric.2026.06.007","relation":{},"ISSN":["1064-9689"],"issn-type":[{"value":"1064-9689","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MR Imaging of Anal Cancer","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mric.2026.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}